AAPG
Ascentage Pharma
AAPG
AAPG
6 hedge funds and large institutions have $5.21M invested in Ascentage Pharma in 2025 Q1 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
6
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.51M | |
| 2 | +$558K | |
| 3 | +$516K | |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
+$350K |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
+$218K |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MIM
1
Monashee Investment Management
Boston,
Massachusetts
| $3.51M |
|
|||
|
PD
2
Point72 (DIFC)
Dubai,
United Arab Emirates
| $558K |
|
|||
|
XC
3
XY Capital
Central,
Hong Kong
| $516K |
|
|||
|
4
Voloridge Investment Management
Jupiter,
Florida
| $350K |
|
|||
|
5
Verition Fund Management
Greenwich,
Connecticut
| $218K |
|
|||
6
UBS Group
Zurich,
Switzerland
| $54.4K |
|